Oruka Therapeutics (ORKA) EPS (Basic) Growth (3y) (2013 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 19.10% |
| Mar 31, 2024 | 24.86% |
| Dec 31, 2023 | 49.19% |
| Sep 30, 2023 | 32.83% |
| Jun 30, 2023 | 48.45% |
| Mar 31, 2023 | 52.31% |
| Dec 31, 2022 | 51.24% |
| Sep 30, 2022 | 40.51% |
| Jun 30, 2022 | 42.21% |
| Mar 31, 2022 | 50.18% |
| Dec 31, 2021 | 40.72% |
| Sep 30, 2021 | 45.69% |
| Jun 30, 2021 | 50.12% |
| Mar 31, 2021 | 54.95% |
| Dec 31, 2020 | -21.51% |
| Sep 30, 2020 | 5.42% |
| Jun 30, 2020 | -7.36% |
| Mar 31, 2020 | -20.03% |
| Dec 31, 2019 | -14.47% |
| Sep 30, 2019 | -14.22% |
| Jun 30, 2019 | -38.40% |
| Mar 31, 2019 | -66.91% |
| Dec 31, 2018 | -89.98% |
| Sep 30, 2018 | -88.00% |
| Jun 30, 2018 | -58.36% |
| Mar 31, 2018 | -58.30% |
| Dec 31, 2017 | 26.89% |
| Sep 30, 2017 | 19.94% |
| Jun 30, 2017 | -75.05% |
| Mar 31, 2017 | -54.56% |
| Dec 31, 2016 | -79.15% |
| Sep 30, 2016 | -47.17% |
| Jun 30, 2016 | 12.87% |
| Mar 31, 2016 | -4.55% |
| Dec 31, 2015 | 1.16% |
| Sep 30, 2015 | 8.90% |
| Jun 30, 2015 | -6.58% |
| Mar 31, 2015 | -9.66% |
| Dec 31, 2014 | 32.51% |
| Sep 30, 2014 | -64.74% |
| Jun 30, 2014 | -78.28% |
| Mar 31, 2014 | 19.59% |
| Dec 31, 2013 | 23.69% |
| Sep 30, 2013 | 12.64% |
| Jun 30, 2013 | -35.72% |